We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

A Mechanism of Drug Resistance in Breast & Ovarian Cancer

News   Jul 19, 2018 | Original story from The Rockefeller University

 
A Mechanism of Drug Resistance in Breast & Ovarian Cancer

By preventing DNA repair, PARP inhibitor drugs cause cancer cells to accumulate mutated chromosomes, ultimately killing them. Credit: Laboratory of Cell Biology and Genetics at The Rockefeller University

 
 
 

RELATED ARTICLES

Novel Way to Generate Molecules for Drug Development

News

Chemists at The Ohio State University have developed a new and improved way to generate molecules that can enable the design of new types of synthetic drugs.

READ MORE

Having a Heavier First-Born or Shorter Pregnancy May Increase Mother’s Breast Cancer Risk

News

Short first pregnancies and having a heavier first-born child may slightly increase a mother’s risk of breast cancer, a new study has found.

READ MORE

How to Define Spectrums of Biomarker Outcomes

News

Defining the full spectrum of human disease associated with a biomarker is necessary to advance the biomarker into clinical practice.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE